Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Acta Diabetologica|July 26, 2019
Titration of insulin glargine 100 U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes: results of the TOP-1 real-world studyStefan Pscherer, Helmut Anderten, Martin Pfohl, et al.
Frontiers in Endocrinology|February 26, 2024
Management of pasireotide-induced hyperglycemia in patients with acromegaly: An experts' consensus statementSylvère Störmann, Sebastian M Meyhöfer, Jan B Groener, et al.
Diabetes & Metabolic Syndrome|September 1, 2016
Titration of basal insulin or immediate addition of rapid acting insulin in patients not at target using basal insulin supported oral antidiabetic treatment - A prospective observational study in 2202 patientsThorsten Siegmund, Martin Pfohl, Thomas Forst, et al.
Endocrinology|March 24, 2011
Protein phosphatase 1 (PP-1)-dependent inhibition of insulin secretion by leptin in INS-1 pancreatic β-cells and human pancreatic isletsPeter Kuehnen, Katharina Laubner, Klemens Raile, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|September 17, 2022
Impact of duodenal-jejunal bypass liner (DJBL) on NAFLD in patients with obesity and type 2 diabetes mellitusNatascha Roehlen, Katharina Laubner, Leonard Nicolaus, et al.
Diabetes, Obesity & Metabolism|May 10, 2019
Predictors of treatment response in type-2 diabetes patients initiating basal-supported oral therapy with insulin glargine 100 U/mL: A sub-analysis of the Titration and OPtimisation (TOP) registryMartin Pfohl, Stefan Pscherer, Andreas Fritsche, et al.
Diabetes, Obesity & Metabolism|September 19, 2018
Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugsJochen Seufert, Andreas Fritsche, Stefan Pscherer, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2018
17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5Natascha Roehlen, Hanna Hilger, Friedrich Stock, et al.
Stem Cells and Development|November 10, 2009
Functional signature of human islet-derived precursor cells compared to bone marrow-derived mesenchymal stem cellsCatarina Limbert, Regina Ebert, Tatjana Schilling, et al.
Diabetes, Obesity & Metabolism|February 22, 2023
iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world dataCristian Guja, János Tibor Kis, Martin Haluzík, et al.
Pageof 15